Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
Yu Jun Wong(National University of Singapore), Juan G. Abraldeṣ(Centro de Investigación Biomédica en Red), Pimsiri Sripongpun(Prince of Songkla University), Jing Hieng Ngu(Christchurch Hospital), Huttakan Navadurong(Chulalongkorn University), Thaninee Prasoppokakorn(Chulalongkorn University), Massimo Primignani(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Asim Abdulhamid(Christchurch Hospital), Giulia Tosetti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Vincent Chen(University of Michigan), Apichat Kaewdech(Prince of Songkla University), Kai Le Ashley Tiong(Changi General Hospital), Jessica Cristiu(University of Michigan), Michael Song(University of Michigan), Pooja Devan(Changi General Hospital), Sombat Treeprasertsuk(Thai Red Cross Society), Jean Ee Neo(Changi General Hospital), Catherine Stedman(Christchurch Hospital)
Cited by 27
Related Papers
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Global burden of metabolic diseases, 1990–2021
|Metabolism|2024|294